The Personalized Medicine Coalition and Turning the Tide Against Cancer Through Sustained Medical Innovation.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 350
- By:
- Publication type:
- Article
Works matching IS 21660166 AND DT 2014 AND VI 3 AND IP 6
Results: 18
1
2
Determining the Value of Cancer Therapies: A Paradigm Shift Focused on Quality, Outcomes, and Cost.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 348
- By:
- Publication type:
- Article
3
Patients Want But Aren't Getting Up-Front Discussions About the Cost of Their Cancer Therapy.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 347
- Publication type:
- Article
4
Site of Service Influences Value.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 346
- Publication type:
- Article
5
ASCO Beginning to Address Value.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 345
- Publication type:
- Article
6
Ramucirumab Conveys Survival Beneit in NSCLC.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 344
- Publication type:
- Article
7
Are Hospital Readmissions for Cancer Patients Preventable?
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 343
- Publication type:
- Article
8
Cancer Patients, By and Large, Not Pursuing Costly, Excessive Tests.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 342
- Publication type:
- Article
9
Routine Imaging Costly in B-Cell Lymphoma but Rarely Picks Up Relapse After Remission.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 341
- Publication type:
- Article
10
Pharmacokinetic-Guided Dosing of 5-FU Shown Cost-Effective.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 340
- Publication type:
- Article
11
ASCO Workgroup Proposes Consolidated Payments for Oncology Care.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 339
- Publication type:
- Article
12
What Makes a Treatment "Clinically Meaningful"?
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 338
- Publication type:
- Article
13
AGENDA.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 337
- Publication type:
- Article
14
Navigating the Molecular Testing Landscape in Lung Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 334
- Publication type:
- Article
15
Highlights From the 6th International Symposium on Acute Promyelocytic Leukemia.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 324
- By:
- Publication type:
- Article
16
FDA Approves Pembrolizumab for Advanced Melanoma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 320
- Publication type:
- Article
17
Tissue Phenomics: Closing the Gap Between Genomic Information and Patient Outcomes.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 314
- By:
- Publication type:
- Article
18
PMO: Recognizing the Many Principles Governing the Personalized Medicine Movement.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 6, p. 313
- By:
- Publication type:
- Article